FNY Investment Advisers’s Ensysce Biosciences ENSC Stock Holding History

FNY Investment Advisers’s Portfolio ENSC Stock Details ENSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	3,000	–	–	﹤0.01%	915
2026 Q1	$1K	Hold	3,000	–	–	﹤0.01%	699
2025 Q4	$2K	Hold	3,000	–	–	﹤0.01%	796
2025 Q3	$7K	Hold	3,000	–	–	﹤0.01%	856
2025 Q2	$6K	Hold	3,000	–	–	﹤0.01%	719
2025 Q1	$7K	Hold	3,000	–	–	﹤0.01%	537
2024 Q4	$24K	Buy	+3,000	New	+$20.7K	0.01%	407
2022 Q4	–	Hold	0	–	–	–	560
2022 Q3	–	Hold	0	–	–	–	699
2022 Q2	–	Hold	0	–	–	–	753
2022 Q1	–	Hold	0	–	–	–	789
2021 Q4	–	Sell	-9	Closed	-$103K	–	624
2021 Q3	$103K	Buy	+9	New	+$176K	0.05%	227

Other funds holding ENSC

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FNY Investment Advisers's ENSC Position: Q2 2026 in Review

FNY Investment Advisers held its Ensysce Biosciences (ENSC) position steady in Q2 2026 at 3,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #915.

FNY Investment Advisers first reported a position in ENSC in Q3 2021 and has held it in 8 quarters since. The position peaked at $103K in Q3 2021. 3 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

FNY Investment Advisers held 3,000 shares of Ensysce Biosciences worth $0 as of Q2 2026.
FNY Investment Advisers left its Ensysce Biosciences share count unchanged in Q2 2026.
Ensysce Biosciences made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #915 holding.
FNY Investment Advisers first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 8 quarters since.
FNY Investment Advisers's Ensysce Biosciences position peaked at $103K in Q3 2021.
3 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.